已收录 273081 条政策
 政策提纲
  • 暂无提纲
Management of asymptomatic hyperuricemia in chronic kidney disease: A proposed stepwise approach
[摘要] Serum uric acid levels are frequently elevated in patients with chronic kidney disease (CKD). The relatively modest hyperuricaemia in CKD may reflect the reduced efficiency of renal excretion of urate. In the past two decades, basic research has shown that hyperuricaemia plays a causal role in the progression of CKD through direct renal injury. However, clinical studies have reported conflicting results, hence there is much controversy about the scope of treating asymptomatic hyperuricaemia to prevent or reduce the rate of CKD progression. In this review, we highlight the most recent guidelines and clinical trials that tested the use of urate-lowering therapy in the management of asymptomatic hyperuricaemia in CKD patients.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 数学(综合)
[关键词] uric acid;hyperuricaemia;chronic kidney disease [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文